Looking to accelerate your stem cell therapy research? Creative Biolabs is pleased to launch its innovative set of induced pluripotent stem cell (iPSC)-based solutions. iPSCs, isolated from adult somatic cells, possess the unique ability to differentiate into any cell type within the human body. This
The “Biorefinery Market by Technology (Industrial Biotechnology, Physico-Chemical, Thermochemical), Product (Energy, Material), Type (First Generation (Corn, Vegetable Oils, Sugarcane), Second Generation, Third Generation) and Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The biorefinery market is expected to grow from an estimated USD 212.05
The Key Fanconi Anemia Companies in the market include – Rocket Pharma, Foresee Pharmaceuticals, Jasper Therapeutics, Novartis, and others. DelveInsight’s “Fanconi Anemia Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Fanconi Anemia, historical and forecasted epidemiology as well as the Fanconi Anemia
Updated capabilities and continued growth reflect the brand’s modern approach to life sciences manufacturing JERSEY CITY, N.J., November 7, 2022 – Apprentice, provider of one platform to turn molecules into medicine, today announced the release of new functionality to its Tempo Manufacturing Cloud and stellar Q3 growth despite
Collaboration with National 4-H Council and Pheasants Forever extends to new sites and students INDIANAPOLIS, JUNE 21, 2022 – Corteva Agriscience today announced the expansion of the Corteva Agriscience Grows Pollinator Habitat Program, supporting monarch butterfly and pollinator habitat creation across the United States. In
National Eye Institute (NEI) to Collaborate with Curative Biotechnology under Cooperative Research and Development Agreement (CRADA) Boca Raton, FL, May 3, 2022 — Curative Biotechnology, Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for rare diseases and
VANCOUVER, BC, April 30, 2022 – HAVN Life Sciences Inc. (CSE:HAVN) (OTC:HAVLF) (FSE:5NP), a biotechnology company pursuing standardized extraction of psychedelic compounds for investigational research as potential APIs to support brain health and cognitive function, today announced that it will be presenting at the Planet MicroCap Showcase 2022
